AQR Arbitrage LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 2 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q3 2021$6,064,000
-22.0%
5,625,000
-26.2%
0.17%
-20.5%
Q2 2021$7,778,000
+1.6%
7,625,0000.0%0.22%
-20.4%
Q1 2021$7,658,000
+0.6%
7,625,0000.0%0.28%
+3.0%
Q4 2020$7,613,000
+3.9%
7,625,0000.0%0.27%
+0.4%
Q3 2020$7,326,000
-55.3%
7,625,000
-53.9%
0.27%
-63.5%
Q2 2020$16,388,000
+6.1%
16,543,0000.0%0.73%
+41.3%
Q1 2020$15,441,000
-18.3%
16,543,000
-11.9%
0.52%
+61.8%
Q4 2019$18,903,000
-3.4%
18,768,000
-9.5%
0.32%
+11.5%
Q3 2019$19,576,000
-14.7%
20,743,000
-5.0%
0.29%
+9.6%
Q2 2019$22,962,000
-11.6%
21,843,000
-14.5%
0.26%
-19.9%
Q1 2019$25,977,000
-6.1%
25,543,0000.0%0.33%
-14.2%
Q4 2018$27,666,000
+6.6%
25,543,0000.0%0.38%
+27.1%
Q3 2018$25,942,000
+4.3%
25,543,0000.0%0.30%
-2.3%
Q2 2018$24,877,000
-14.4%
25,543,000
-5.5%
0.31%
-9.2%
Q1 2018$29,055,000
-6.3%
27,018,000
-13.5%
0.34%
-8.2%
Q4 2017$31,023,000
+1.3%
31,218,0000.0%0.37%
+10.9%
Q3 2017$30,613,000
+7.3%
31,218,0000.0%0.33%
+6.1%
Q2 2017$28,525,000
-3.7%
31,218,0000.0%0.31%
-6.6%
Q1 2017$29,618,000
+11.3%
31,218,0000.0%0.33%
+21.0%
Q4 2016$26,613,000
+253.0%
31,218,000
+248.8%
0.28%
+273.0%
Q3 2016$7,540,0008,950,0000.07%
Other shareholders
THERAVANCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 500,000$491,0000.40%
Walleye Capital LLC 19,788,000$19,514,0000.37%
WOLVERINE ASSET MANAGEMENT LLC 27,976,000$27,582,0000.30%
SSI INVESTMENT MANAGEMENT LLC 3,410,000$3,350,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 14,002,000$13,808,0000.15%
Radcliffe Capital Management, L.P. 5,000,000$4,912,0000.12%
D. E. Shaw & Co., Inc. 11,336,000$11,220,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 1,060,000$1,041,0000.01%
TORONTO DOMINION BANK 5,450,000$5,336,0000.01%
Russell Investments Group, Ltd. 2,621,000$2,601,0000.01%
View complete list of THERAVANCE INC shareholders